Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma

Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

Louise Davies, H. Gilbert Welch · JAMA · 2006 · 3.4K citations

Medicine, Oncology, Pathology +16

Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples

Yuri E. Nikiforov, N. Paul Ohori, Steven P. Hodak et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 789 citations · Full text

Medicine, Genetics, Pathology +13

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

David Capper, Matthias Preusser, Antje Habel et al. · Acta Neuropathologica · 2011 · 472 citations

Medicine, Genetics, Oncology +9

Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma

Georgina V. Long, James S. Wilmott, David Capper et al. · The American Journal of Surgical Pathology · 2012 · 300 citations

Medicine, Oncology, Pathology +15

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

David Capper, Anna S. Berghoff, Manuel Magerle et al. · Acta Neuropathologica · 2011 · 213 citations

Medicine, Oncology, Pathology +17